A high impact program for accelerated deployment with regulatory & funding support.
AIC-CCMB has initiated several activities including support for development and validation of novel Covid-19 innovations by start-ups and MSMEs. Our goal is to support and rapidly deploy diagnostics and therapeutics through the participation of research institutes, industries, policy maker and incubators.
As the pandemic wages in the country with devastating consequences, AIC-CCMB is inviting entrepreneurs and innovators with promising technologies to join our Covid-19 Technology Deployment (CoviTeD) Acceleration Program. A CSR initiative of Security Printing and Minting Corporation of India Limited (SPMCIL), the CoviTeD program aim to provide high impact mentoring, financial, regulatory and marketing support to take these products and technologies to market.
Our Focus ares:
· Medical devices for management of covid-19 patients
· Quantifiable tests for ancillary markers of Covid-19
· Rapid Diagnostics
· Drugs & Therapeutics
· Sterilization and hygiene
· Logistics for biologicals
· Post-mortem management
All the proposals shall be considered by a Management Committee (MC) constituted by AIC-CCMB. Only the proposals approved by the MC shall be allowed access to the facility and undertake project work on the agreed terms and conditions for development of innovative products and processes.